Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Biotech
How Peter Marks plans to prevent '3 billion visits' to FDA
Accelerated approval—controversial, yes—but absolutely necessary for small, pre-revenue biotechs, the FDA’s Peter Marks, M.D., Ph.D., said Wednesday.
Annalee Armstrong
May 8, 2024 11:05am
Sanofi CSO Frank Nestle is leaving
May 8, 2024 10:00am
Sponsored
Progress Toward a New GAD Treatment Paradigm
May 6, 2024 8:00am
Marinus lays off 20% to steady ship after IV seizure med issues
May 8, 2024 9:42am
Sponsored
Patient Access and Affordability: PhRMA shares how we can put patients first
Feb 12, 2024 8:00am
Compass tracks PTSD improvements in midphase psilocybin trial
May 8, 2024 8:07am